News of the WeekSTEM CELL RESEARCH

Harvard Cloners Get OK to Proceed With Caution

+ See all authors and affiliations

Science  16 Jun 2006:
Vol. 312, Issue 5780, pp. 1584
DOI: 10.1126/science.312.5780.1584b

You are currently viewing the summary.

View Full Text

Summary

Harvard University researchers last week were given the go-ahead to use cloning to create disease-specific lines of human embryonic stem cells, making Harvard the second U.S. academic institution to use research cloning as a tool for studying diseases such as diabetes and Parkinson's. (Read more.)